Clover Biopharmaceuticals, Ltd.

HKEX:2197.HK

0.86 (HKD) • At close August 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

202420232022202120202019
Operating Activities:
Net Income -903.428-138.539-2,451.903-6,016.303-912.898-48.583
Depreciation & Amortization 074.74260.09425.3895.7842.397
Deferred Income Tax 00065.89900
Stock Based Compensation 16.27853.51595.023125.21400
Change In Working Capital 040.21156.6341,077.088751.50718.566
Accounts Receivables 0-24.1060000
Inventory 0-8.697-2,090.396-771.654-50.488-0.393
Accounts Payables 000000
Other Working Capital -151.94173.0142,147.031,848.742801.99518.959
Other Non Cash Items 598.664-757.807549.3433,804.964632.5341.003
Operating Cash Flow -288.486-727.878-1,690.809-917.749476.927-26.617
Investing Activities:
Investments In Property Plant And Equipment 0-6.952-105.56-80.316-113.792-6.816
Acquisitions Net 00021.06400
Purchases Of Investments 00-13.929-30-280.3280
Sales Maturities Of Investments 4.7243.01579.782222.4400
Other Investing Activites -1.556-2.2242.201-21.064-280.5064.218
Investing Cash Flow 3.168-6.161-37.506112.124-394.12-2.598
Financing Activities:
Debt Repayment -234.332-28.568293.8330-4.4720
Common Stock Issued 0.0050.084453.1551,750.029-0.3270
Common Stock Repurchased 000000
Dividends Paid 000-100.5900
Other Financing Activities 182.828-113.924-263.8451,407.734321.319142.05
Financing Cash Flow -51.499-142.408483.1433,057.173316.847142.05
Other Information:
Effect Of Forex Changes On Cash 04.90285.21-0.361-32.1640.115
Net Change In Cash -334.621-871.545-1,159.9622,251.187367.49112.95
Cash At End Of Period 401.243735.8641,607.4092,767.371516.184148.694